"CONCLUSIONS
Oral nicotinamide was safe and effective in reducing the rates of new nonmelanoma skin cancers and actinic keratoses in high-risk patients. (Funded by the National Health and Medical Research Council; ONTRAC Australian New Zealand Clinical Trials Registry number, ACTRN12612000625875.)"
http://www.nejm.org/doi/full/10.1056/NEJMoa1506197
No comments:
Post a Comment